Literature DB >> 19897745

Role of cholesterol in the biophysical dysfunction of surfactant in ventilator-induced lung injury.

Dan Vockeroth1, Lasantha Gunasekara, Matthias Amrein, Fred Possmayer, James F Lewis, Ruud A W Veldhuizen.   

Abstract

Mechanical ventilation may lead to an impairment of the endogenous surfactant system, which is one of the mechanisms by which this intervention contributes to the progression of acute lung injury. The most extensively studied mechanism of surfactant dysfunction is serum protein inhibition. However, recent studies indicate that hydrophobic components of surfactant may also contribute. It was hypothesized that elevated levels of cholesterol significantly contribute to surfactant dysfunction in ventilation-induced lung injury. Sprague-Dawley rats (n = 30) were randomized to either high-tidal volume or low-tidal volume ventilation and monitored for 2 h. Subsequently, the lungs were lavaged, surfactant was isolated, and the biophysical properties of this isolated surfactant were analyzed on a captive bubble surfactometer with and without the removal of cholesterol using methyl-beta-cyclodextrin. The results showed lower oxygenation values in the high-tidal volume group during the last 30 min of ventilation compared with the low-tidal volume group. Surfactant obtained from the high-tidal volume animals had a significant impairment in function compared with material from the low-tidal volume group. Removal of cholesterol from the high-tidal volume group improved the ability of the surfactant to reduce the surface tension to low values. Subsequent reconstitution of high-cholesterol values led to an impairment in surface activity. It is concluded that increased levels of cholesterol associated with endogenous surfactant represent a major contributor to the inhibition of surfactant function in ventilation-induced lung injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19897745     DOI: 10.1152/ajplung.00218.2009

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  25 in total

1.  Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.

Authors:  Elena López-Rodríguez; Olga Lucía Ospina; Mercedes Echaide; H William Taeusch; Jesús Pérez-Gil
Journal:  Biophys J       Date:  2012-10-02       Impact factor: 4.033

Review 2.  A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.

Authors:  Michael B Fessler
Journal:  Ann Am Thorac Soc       Date:  2017-11

3.  Emerging roles for cholesterol and lipoproteins in lung disease.

Authors:  Kymberly M Gowdy; Michael B Fessler
Journal:  Pulm Pharmacol Ther       Date:  2012-06-15       Impact factor: 3.410

4.  Pulmonary surfactant proteins and polymer combinations reduce surfactant inhibition by serum.

Authors:  Karen W Lu; Jesús Pérez-Gil; Mercedes Echaide; H William Taeusch
Journal:  Biochim Biophys Acta       Date:  2011-06-27

5.  Effect of cholesterol nanodomains on monolayer morphology and dynamics.

Authors:  Kyuhan Kim; Siyoung Q Choi; Zachary A Zell; Todd M Squires; Joseph A Zasadzinski
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-30       Impact factor: 11.205

Review 6.  Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung Disease.

Authors:  Michael B Fessler; Ross S Summer
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

7.  A ToF-SIMS study of the lateral organization of lipids and proteins in pulmonary surfactant systems.

Authors:  Eleonora Keating; Alan J Waring; Frans J Walther; Fred Possmayer; Ruud A W Veldhuizen; Nils O Petersen
Journal:  Biochim Biophys Acta       Date:  2010-11-24

8.  Low-dose cadmium disrupts mitochondrial citric acid cycle and lipid metabolism in mouse lung.

Authors:  Xin Hu; Joshua D Chandler; Soojin Park; Ken Liu; Jolyn Fernandes; Michael Orr; M Ryan Smith; Chunyu Ma; Sang-Moo Kang; Karan Uppal; Dean P Jones; Young-Mi Go
Journal:  Free Radic Biol Med       Date:  2018-12-06       Impact factor: 7.376

9.  Surfactant Dysfunction in ARDS and Bronchiolitis is Repaired with Cyclodextrins.

Authors:  Mustafa Al-Saiedy; Lasantha Gunasekara; Francis Green; Ryan Pratt; Andrea Chiu; Ailian Yang; John Dennis; Cora Pieron; Candice Bjornson; Brent Winston; Matthias Amrein
Journal:  Mil Med       Date:  2018-03-01       Impact factor: 1.437

10.  Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease.

Authors:  Blair R Roszell; Jian-Qin Tao; Kevin J Yu; Ling Gao; Shaohui Huang; Yue Ning; Sheldon I Feinstein; Charles H Vite; Sandra R Bates
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.